The Career Development Program is designed to provide training and guidance for academic physician scientists, clinician-investigators and laboratory-based scientists who wish to dedicate their efforts to translational research in the area of diagnosis, prevention and treatment of breast cancer. In order to meet this goal, the Career Development Program has developed these specific objectives: 1. To recruit and train physicians and scientists to become outstanding translational investigators in the field of breast cancer; 2. To educate awardees in the basic principles of cancer biology, at both the molecular and cellular level, with an emphasis on translational science; 3. To provide a firm foundation for awardees in the specific area of breast cancer biology, laboratory, clinical and epidemiologic evaluation; 4. To guide awardees through the development process of becoming effective breast cancer translational researchers. We will achieve these objectives through a strong mentorship program in which awardees will be instructed in the principles of clinical and epidemiological breast cancer, combined with basic science studies of cell biology and cancer biology. The Career Development Program will recruit senior medical or laboratory-based postdoctoral fellows and junior faculty who wish to develop a career in translational research focussed on breast cancer;in addition, established senior faculty who wish to re-direct or extend their ongoing research programs will be eligible for participation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA116199-05
Application #
7906043
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
2012-08-31
Budget Start
2009-09-01
Budget End
2012-08-31
Support Year
5
Fiscal Year
2009
Total Cost
$128,739
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Nanos-Webb, A; Bui, T; Karakas, C et al. (2016) PKCiota promotes ovarian tumor progression through deregulation of cyclin E. Oncogene 35:2428-40
Jabbour-Leung, Natalie A; Chen, Xian; Bui, Tuyen et al. (2016) Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer. Mol Cancer Ther 15:593-607
Lucenay, Kimberly S; Doostan, Iman; Karakas, Cansu et al. (2016) Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells. Cancer Res 76:2406-18
Gaur, Sanchaika; Wen, Yunfei; Song, Jian H et al. (2015) Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy. Oncotarget 6:29161-77
Wen, Yunfei; Graybill, Whitney S; Previs, Rebecca A et al. (2015) Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer. Clin Cancer Res 21:448-59
Qi, Yuan; Liu, Xiuping; Liu, Chang-Gong et al. (2015) Reproducibility of Variant Calls in Replicate Next Generation Sequencing Experiments. PLoS One 10:e0119230
Guan, Xiaoxiang; Liu, Hongliang; Ju, Jingfang et al. (2015) Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ? 55 years. Mol Carcinog 54:281-90
Gutierrez-Rubio, S A; Quintero-Ramos, A; Durán-Cárdenas, A et al. (2015) 1236 C/T and 3435 C/T polymorphisms of the ABCB1 gene in Mexican breast cancer patients. Genet Mol Res 14:1250-9
Nodora, Jesse N; Cooper, Renee; Talavera, Gregory A et al. (2015) Acculturation, Behavioral Factors, and Family History of Breast Cancer among Mexican and Mexican-American Women. Womens Health Issues 25:494-500
Wen, Yunfei; Zand, Behrouz; Ozpolat, Bulent et al. (2014) Antagonism of tumoral prolactin receptor promotes autophagy-related cell death. Cell Rep 7:488-500

Showing the most recent 10 out of 137 publications